129 filings
Page 3 of 7
8-A12B
1rb0byzps n9
29 Sep 23
Registration of securities on exchange
12:03pm
424B3
2wkan8
22 Sep 23
Prospectus supplement
4:08pm
425
v065c
22 Sep 23
Business combination disclosure
12:55pm
8-K
fbabif18
22 Sep 23
Entry into a Material Definitive Agreement
12:55pm
425
jw1o06lvhu
22 Sep 23
Business combination disclosure
9:27am
8-K
5jz259 ka6cpiux
22 Sep 23
Graf Acquisition Corp. IV Announces Adjournment of Special Meeting
9:26am
424B3
cii6 v6lwx
21 Sep 23
Prospectus supplement
7:31pm
425
4w5hr25s n7
19 Sep 23
Business combination disclosure
3:52pm
8-K
01wzd3cxtgy1epzfi6q
19 Sep 23
Entry into a Material Definitive Agreement
3:51pm
425
gh1zt 24v
18 Sep 23
Business combination disclosure
9:26am
8-K
2raka rymj
18 Sep 23
Entry into a Material Definitive Agreement
9:25am
425
6pn6yk3u
14 Sep 23
Business combination disclosure
9:31am
8-K
cat8hhh6f4eb3
14 Sep 23
Graf Acquisition Corp. IV Announces Adjournment of Special Meeting
9:30am
425
dcynbsj4f 5n3b
11 Sep 23
Business combination disclosure
11:30am
8-K
x4bnxe
11 Sep 23
Graf Acquisition Corp. IV Announces Adjournment of Special Meeting
11:30am
425
ywx y9rp2
30 Aug 23
Business combination disclosure
7:30am
8-K
iyf71ye5ce47
30 Aug 23
Graf Acquisition Corp. IV Announces Intent to Adjourn Special Meeting
7:30am
425
f708ikbz52
24 Aug 23
Business combination disclosure
8:15am
425
altlgk o9a
15 Aug 23
Business combination disclosure
4:31pm
8-K
23xi6
15 Aug 23
Graf Acquisition Corp. Iv and Nkgen Biotech, Inc. Announce Effectiveness of Form S-4 for Proposed Business Combination
4:30pm